Domitilla Picozzi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Domitilla Picozzi has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Andrea Piccioni
Department of Emergency Medicine, Università Cattolica del Sacro Cuore, Rome, Italy
1 shared publication - Francesco Franceschi
Department of Emergency Medicine, Policlinico Gemelli/IRCCS, University of Catholic of Sacred Heart, 00168 Rome, Italy
1 shared publication - Giulia Pignataro
Emergency, Anesthesiological and Reanimation Sciences Department, Fondazione Policlinico Universitario A. Gemelli—IRCCS of Rome, 00168 Rome, Italy
1 shared publication - Marcello Candelli
Department of Emergency, Anesthesiological and Reanimation Sciences, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 00168 Rome, Italy
1 shared publication - Sara Cicchinelli
Department of Emergency, S.S. Filippo e Nicola Hospital, 67051 Avezzano, Italy
1 shared publication - Stefania Gemma
Emergency Department, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 12 January 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (2) , 962
PAMPs and DAMPs in Sepsis: A Review of Their Molecular Features and Potential Clinical Implications
Sepsis is a serious organ dysfunction caused by a dysregulated immune host reaction to a pathogen. The innate immunity is programmed to react immediately to conserved molecules, released by the pathogens (PAMPs), and the host (DAMPs). We aimed to review the molecular mechanisms of the early phases of sepsis, focusing on PAMPs, DAMPs, and their related pathways, to identify potential biomarkers. We included studies published in English and searched on PubMed® and Cochrane®. After a detailed discussion on the actual knowledge of PAMPs/DAMPs, we analyzed their role in the different organs affected by sepsis, trying to elucidate the molecular basis of some of the most-used prognostic scores for sepsis. Furthermore, we described a chronological trend for the release of PAMPs/DAMPs that may be useful to identify different subsets of septic patients, who may benefit from targeted therapies. These findings are preliminary since these pathways seem to be strongly influenced by the peculiar characteristics of different pathogens and host features. Due to these reasons, while initial findings are promising, additional studies are necessary to clarify the potential involvement of these molecular patterns in the natural evolution of sepsis and to facilitate their transition into the clinical setting.
- 12 January 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (2) , 962
Top Cited PapersOpen AccessPAMPs and DAMPs in Sepsis: A Review of Their Molecular Features and Potential Clinical Implications
Sepsis is a serious organ dysfunction caused by a dysregulated immune host reaction to a pathogen. The innate immunity is programmed to react immediately to conserved molecules, released by the pathogens (PAMPs), and the host (DAMPs). We aimed to review the molecular mechanisms of the early phases of sepsis, focusing on PAMPs, DAMPs, and their related pathways, to identify potential biomarkers. We included studies published in English and searched on PubMed® and Cochrane®. After a detailed discussion on the actual knowledge of PAMPs/DAMPs, we analyzed their role in the different organs affected by sepsis, trying to elucidate the molecular basis of some of the most-used prognostic scores for sepsis. Furthermore, we described a chronological trend for the release of PAMPs/DAMPs that may be useful to identify different subsets of septic patients, who may benefit from targeted therapies. These findings are preliminary since these pathways seem to be strongly influenced by the peculiar characteristics of different pathogens and host features. Due to these reasons, while initial findings are promising, additional studies are necessary to clarify the potential involvement of these molecular patterns in the natural evolution of sepsis and to facilitate their transition into the clinical setting.